Research use only.

The products on this site are supplied strictly for laboratory and research purposes. They are not for human consumption, ingestion, or administration, and nothing here is a medical claim.

By entering, you confirm you are 21 or older and understand these terms.

INCLUDED WITH EVERY ORDER1 month subscription of BioTrackr app — independent health tracker and analytics.biotrackr.net →
Nootropic-peptide research

Semax vs Selank: Origin, Structure & Research Focus

Semax vs selank — two synthetic heptapeptides from the same Russian laboratory that are often compared. This page sets them side by side by origin, peptide structure and the mechanisms the literature has examined. It is framed as research focus only, with no cognitive or anxiety-related benefit claims.

RESEARCH USE ONLY. Cellworks supplies compounds strictly for in-vitro laboratory research. Nothing on this page is a medical, efficacy, or dosing claim, and no product is for human or veterinary use.

Two peptides from one Russian lab

Both semax and selank are synthetic heptapeptides — chains of seven amino acids — developed at the Institute of Molecular Genetics of the Russian Academy of Sciences. That shared institutional origin, together with their common seven-residue length, is the main reason the two are so routinely set against each other: they come from the same research lineage and occupy the same size class. Peptides in this range are short enough to synthesise readily and to characterise precisely, which is part of why both became fixtures in the nootropic-research catalogue.

The similarity, though, largely stops at origin and length. Their parent molecules are unrelated and the mechanisms the literature has studied for each are quite different. Selank is a nootropic-research peptide derived from the endogenous immunopeptide tuftsin, while semax is derived from a fragment of the hormone ACTH. Holding those two facts — same lab, different parent molecule — is the frame for everything below.

Side-by-side comparison table

Origin, amino-acid sequence and the primary mechanism each peptide has been studied under, side by side. The sequences are molecule facts; the mechanism and research-focus columns describe what the literature has investigated, not effects a reader would obtain.

PeptideDerived fromSequencePrimary mechanism studiedResearch focus area
SemaxACTH(4-10) analogMet-Glu-His-Phe-Pro-Gly-ProBDNF / NGF upregulationCognitive / neurotrophic research
SelankTuftsin derivativeThr-Lys-Pro-Arg-Pro-Gly-ProGABAergic modulationAnxiolytic / stress research

Semax — origin & mechanisms researchers examined

Semax is described in the literature as an analog of ACTH(4-10) — a short stretch of the adrenocorticotropic hormone sequence — with additional residues that distinguish it from the natural fragment. Its full sequence is Met-Glu-His-Phe-Pro-Gly-Pro. That ACTH-fragment origin is the structural fact that sets it apart from selank, whose parent is entirely different.

In semax research, the published studies have most often investigated its relationship to neurotrophic factors — proteins involved in the growth and maintenance of neurons — with brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) the two most frequently named. This work has typically been carried out in hippocampal and cortical model systems. The consistent framing across the literature is neurotrophic and cognitive: these are the questions researchers set out to examine, cited here as “studies investigated,” and are not presented as an effect a reader would obtain from the peptide. For Semax’s own literature in depth — the BDNF/TrkB and dopaminergic mechanisms, ischemia models, and the Russian-published record — see the Semax research deep-dive.

Selank — origin & mechanisms researchers examined

Selank is a synthetic derivative of tuftsin, an endogenous immunomodulatory peptide that occurs naturally as a fragment of an antibody molecule. Its sequence is Thr-Lys-Pro-Arg-Pro-Gly-Pro. Where semax traces back to a hormone fragment, selank traces back to this immunopeptide — the same seven-residue length, a completely different lineage.

The published research on selank has examined a different set of pathways from semax. Studies have looked at its influence on GABAergic tone — signalling associated with the brain’s principal inhibitory neurotransmitter system — and at its effect on the metabolism of enkephalins, a class of endogenous peptides. On the strength of that work the literature situates selank in anxiolytic and stress-related research contexts. As with semax, these are research directions that have been studied and are described here neutrally, without any claim about what the peptide does in a person. Selank’s own literature — the GABAergic, BDNF, enkephalin and neuroimmune work, and the honest treatment of the Russian evidence — is covered in the Selank research deep-dive.

How their research focus differs

The cleanest way to hold the two peptides apart is by research arm rather than by any notion of which is “stronger.” The semax literature is organised around pro-cognitive and neurotrophic questions — BDNF/NGF expression, cortical and hippocampal models. The selank literature is organised around anxiolytic and stress-modulating questions — GABAergic tone and enkephalin metabolism. Same lab, same length, but two distinct research programs pointed at different biology.

It is important to read those descriptions for exactly what they are: research focus areas, meaning the directions studies have taken, not effects the reader will experience. This page deliberately draws no “which is better” conclusion and offers no recommendation between them. A verdict of that kind — or any claim that one boosts focus or the other reduces anxiety — would be a benefit claim, and we make none. What the comparison supports is a map of origin, structure and the questions each peptide has been investigated under.

Research-grade sourcing & verification

For nootropic-research peptides in particular, where the useful literature is specific to a precisely-made sequence, knowing exactly what is in the vial matters. Cellworks supplies both semax and selank for research use only, each with a per-batch Certificate of Analysis reporting HPLC purity (%), mass-spec identity confirmation and a lot number you can check yourself on the self-serve verify tool. See our quality standards for how each batch is tested and recorded, or browse the wider neuro-research range on /shop.

Semax 11 mgSelank 11 mg

Verify a batch

Every order ships with a per-batch Certificate of Analysis. Have a vial in hand? Enter its lot number to look up the COA for that exact batch.

FAQ

Are semax and selank the same?
No. They are two distinct synthetic heptapeptides that happen to share an origin — the same Russian institute — and a length of seven amino acids. Beyond that they differ in almost every way that matters: different parent molecules, different amino-acid sequences, and different mechanisms in the research literature. Same lab and same size, but not the same peptide.
What is semax derived from?
Semax is described in the literature as an analog of a fragment of the hormone ACTH — specifically the ACTH(4-10) stretch — with additional residues that distinguish it from the natural fragment. Its full amino-acid sequence is Met-Glu-His-Phe-Pro-Gly-Pro. That hormone-fragment origin is the structural fact that separates it from selank.
What is selank derived from?
Selank is described as a synthetic derivative of tuftsin, an endogenous immunomodulatory peptide that occurs naturally as a fragment of an antibody molecule. Its sequence is Thr-Lys-Pro-Arg-Pro-Gly-Pro. Where semax traces back to a hormone fragment, selank traces back to this immunopeptide — the same length, a completely different lineage.
Where were semax and selank developed?
Both were developed at the Institute of Molecular Genetics of the Russian Academy of Sciences. That shared institutional origin, together with their common seven-residue length, is the main reason the two peptides are so routinely compared with one another.

RESEARCH USE ONLY — NOT FOR HUMAN CONSUMPTION. All products are sold strictly for in-vitro laboratory research and are not intended for human or veterinary use, ingestion, or administration. Nothing on this page is a medical or efficacy claim. You must be 21 or older to browse this catalog.